Trimetazidine ameliorates sunitinib-induced cardiotoxicity in mice via the AMPK/mTOR/autophagy pathway

Context: Sunitinib (SU) is a multi-targeted tyrosine kinase inhibitor anticancer agent whose clinical use is often limited by cardiovascular complications. Trimetazidine (TMZ) is an anti-angina agent that has been demonstrated cardioprotective effects in numerous cardiovascular conditions, but its p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yi, Li, Na, Chen, Tongshuai, Zhang, Chunmei, Liu, Lingxin, Qi, Yan, Bu, Peili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764339/
https://www.ncbi.nlm.nih.gov/pubmed/31545912
http://dx.doi.org/10.1080/13880209.2019.1657905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764339/
https://www.ncbi.nlm.nih.gov/pubmed/31545912
http://dx.doi.org/10.1080/13880209.2019.1657905

Ejemplares similares